Fibrinogen and cardiovascular disease

被引：22

作者：

Meade, TW ^{[1
]}

机构：

[1] ROYAL LONDON SCH MED & DENT, LONDON EC1M 6BQ, ENGLAND

来源：

JOURNAL OF CLINICAL PATHOLOGY | 1997年 / 50卷 / 01期

关键词：

D O I：

10.1136/jcp.50.1.13

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：13 / 15

页数：3

共 25 条

[1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[2]

[Anonymous], 1994, Am J Ophthalmol, V118, P754

[3]

BANERJEE AK, 1992, THROMB HAEMOSTASIS, V68, P261

[4]

CLAUSS A, 1957, ACTA HAEMATOL, V17, P565

[5] FIBRINOGEN AS A CARDIOVASCULAR RISK FACTOR - A METAANALYSIS AND REVIEW OF THE LITERATURE [J].

ERNST, E ;

RESCH, KL .

ANNALS OF INTERNAL MEDICINE, 1993, 118 (12) :956-963

[6]

GAFFNEY PJ, 1992, THROMB HAEMOSTASIS, V68, P428

[7] RATIONALE AND DESIGN OF A SECONDARY PREVENTION TRIAL OF INCREASING SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND REDUCING TRIGLYCERIDES IN PATIENTS WITH CLINICALLY MANIFEST ATHEROSCLEROTIC HEART-DISEASE (THE BEZAFIBRATE INFARCTION PREVENTION TRIAL) [J].

GOLDBOURT, U ;

BEHAR, S ;

REICHERREISS, H ;

AGMON, J ;

KAPLINSKY, E ;

GRAFF, E ;

KISHON, Y ;

CASPI, A ;

WEISBORT, J ;

MANDELZWEIG, L ;

ABINADER, E ;

AHARON, L ;

BRAUN, S ;

DAVID, D ;

FLICH, M ;

FRIEDMAN, Y ;

KRISTAL, N ;

LEIL, N ;

MARKIEWICZ, W ;

MARMOR, A ;

PALANT, A ;

PELLED, B ;

RABINOWITZ, B ;

REISIN, L ;

ROGUIN, N ;

ROSENFELD, T ;

SCHLESINGER, Z ;

SCLAROVSKY, S ;

SHERF, L ;

TZIVONI, D ;

ZAHAVI, I ;

ZION, M ;

BRUNNER, D ;

FRIDENSOHN, A ;

JAFARI, J ;

OSTFELD, B ;

ROCHFLEISH, S ;

SCHNEIDER, H ;

KHALID, S ;

NARINSKY, R ;

ROTZAK, R ;

VITRAI, J ;

PELLED, B ;

PARDU, J ;

LANIADO, S ;

ESHCHAR, Y ;

ARDITI, A ;

BOTWIN, S ;

ROGUIN, N ;

YAHALOM, M .

AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (11) :909-915

[8] CHOLESTEROL REDUCTION YIELDS CLINICAL BENEFIT - A NEW LOOK AT OLD DATA [J].

GOULD, AL ;

ROSSOUW, JE ;

SANTANELLO, NC ;

HEYSE, JF ;

FURBERG, CD .

CIRCULATION, 1995, 91 (08) :2274-2282

[9]

HAMSTEN A, 1987, LANCET, V2, P988

[10] THE INFLUENCE OF FIBRINOGEN CONCENTRATION ON THE DEVELOPMENT OF VEIN GRAFT STENOSES [J].

HICKS, RCJ ;

ELLIS, M ;

MIRHASSEINE, R ;

HIGMAN, DJ ;

NOTT, D ;

GREENHALGH, RM ;

POWELL, JT .

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1995, 9 (04) :415-420

← 1 2 3 →